Prostate cancer needs testosterone to grow. In metastatic castration-resistant prostate cancer (mCRPC), an advanced form of the disease, the cancer continues growing despite a reduction in testosterone brought about by chemical or surgical castration. As such, mCRPC has few treatment options and carries a high mortality rate.Continue ReadingCategory: Medical, ScienceTags: Prostate cancer, Immunotherapy, The Immune System
FDA fast-tracks personalized therapy for hard-to-treat-prostate cancer
Posted by ArielTechGeek 256 days ago (https://newatlas.com)
Who Voted for this Story
Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz
a
adventure
apps
architects
architecture
best
chrome
clear
compelling
comprehensive
design
electric
follow
fun
game
games
google
guide
hidden
home
hosting
house
ios
its
list
london
money
mysql
nikon
olympics
plenty
projector
providers
save
secret
studio
text
top
tops
view
Comments